Anti-Mesothelin Car Nk Cells
Endometrial Cancer Recurrent
Second Affiliated Hospital of Guangzhou Medical UniversityCell therapyPhase 1Active
CC
43/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 28/ 100
- Competitive Position
- 95/ 100
Competitive context
4 Active assets in the Endometrial Cancer Recurrent cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
OPB-201 Outpace Bio, Inc. | Phase 1 | CC |
Rhil-7 Second Affiliated Hospital of Guangzhou Medical University | Phase 1 | CC |
CK BETA-11 Second Affiliated Hospital of Guangzhou Medical University | Phase 1 | CC |
NAD(SUP +) Second Affiliated Hospital of Guangzhou Medical University | Phase 1 | CC |
Same molecule, other indications
Anti-Mesothelin Car Nk Cells is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →